Yulong He
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Gastrointestinal Tumor Research and Treatment 29
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 14
- Co-authors
- Jianbo XuShirong CaiChanghua ZhangChuangqi ChenYujie YuanGuanghua LiJianjun PengKaiyu Sun
- Journals
- Frontiers in Oncology (9 papers)Frontiers in Cell and Developmental Biology (6 papers)Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Journal of Cancer Research and Clinical Oncology (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yulong He
241 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.9k
- Oncology 2.3k
- Gastroenterology 377
- Immunology 946
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Yulong He
This map shows the geographic impact of Yulong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulong He more than expected).
Fields of papers citing papers by Yulong He
This network shows the impact of papers produced by Yulong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulong He. The network helps show where Yulong He may publish in the future.
Co-authors
The 25 scholars most cited alongside Yulong He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 17 | |
| 4 | 2023 | 24 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 17 | |
| 8 | An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy Hit paper breakdown → | 2022 | 323 |
| 9 | 2022 | 1 | |
| 10 | Signaling pathways and therapeutic interventions in gastric cancer Hit paper breakdown → | 2022 | 167 |
| 11 | 2022 | 91 | |
| 12 | 2022 | 67 | |
| 13 | 2021 | 53 | |
| 14 | 2021 | 15 | |
| 15 | 2020 | 44 | |
| 16 | 2020 | 56 | |
| 17 | 2019 | 42 | |
| 18 | 2019 | 94 | |
| 19 | 2017 | 17 | |
| 20 | 2014 | 61 |
About Yulong He
Yulong He is a scholar working on Gastroenterology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 250 papers that have together received 7.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (48 papers), RNA modifications and cancer (31 papers), Gastrointestinal Tumor Research and Treatment (29 papers), Cancer-related molecular mechanisms research (24 papers), Metastasis and carcinoma case studies (19 papers), Ferroptosis and cancer prognosis (17 papers), Cancer Mechanisms and Therapy (16 papers) and MicroRNA in disease regulation (14 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.3k citations), Gastroenterology (377 citations), Immunology (946 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Yulong He has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianbo Xu, Shirong Cai, Changhua Zhang, Chuangqi Chen, Yujie Yuan, Guanghua Li, Jianjun Peng, Kaiyu Sun, Ertao Zhai and Shuling Chen. Their work appears in journals such as Frontiers in Oncology, Frontiers in Cell and Developmental Biology, Journal of Cancer, Journal of Clinical Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.